Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Las Abogadas RVA Steps Into Athlete Immigration With Dedicated Sports Visa Services
-
Amotus Achieves Critical Milestone: Daniel Noiseux on CGP Certification and Secure IoT
-
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
-
United Way Fox Cities Selects StratusLIVE Unified Engagement Platform to Modernize Workplace Giving
-
Alithya appoints David Torralbo as new Chief Legal Officer and Corporate Secretary
-
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
-
U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer
-
Identiv Completes Thailand Manufacturing Transition, Unlocking Next-Generation Multicomponent Manufacturing for Advanced IoT Solutions
-
C1 Fund Announces Recent Insider Share Purchases, Reflecting Strong Alignment, Long-Term Confidence
-
Darden Restaurants Reports Fiscal 2026 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2026 Financial Outlook
-
CIBC Innovation Banking Provides $25 Million in Growth Capital to BinSentry
-
D’Antuono Joins Fiduciary Trust Company as VP and Trust Counsel
-
Essential Utilities Shows Holiday Spirit Announcing More than $1.2 Million in Donations Through Two Major Campaigns
-
Atavistik Bio Raises $120 Million Series B Financing to Advance the Development of Selective Allosteric Small Molecule Therapeutics for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) and
-
Del Webb Explore Breaks Ground on Model Homes at North River Ranch
-
Startup World Cup Returns to Las Vegas 2026, Bringing Global Startups and Investors Together
-
Visa and Partners Complete Secure AI Transactions, Setting the Stage for Mainstream Adoption in 2026
-
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
-
AlbaneseCormier Expands National Footprint with Strategic Acquisition of 714,000 Square Foot Open-Air Retail Portfolio
-
New Pipedrive App in ChatGPT Now Available for Pipedrive Customers
-
Files.com Defines the Next Evolution of SFTP and MFT as a File Orchestration Platform
-
Redwire Awarded Contract to Provide Spacecraft Docking Systems for The Exploration Company's European Space Capsule
-
BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
-
Silver Storm Orders La Parrilla Underground Mining Fleet and Ventilation System
-
Robbins Sports Surfaces Becomes Primary Provider of NBA Game Courts
-
SES AI and Top Material Announce Plans to Boost Cell Manufacturing Capacity in Korea for Drone Applications
-
SLR Credit Solutions Agents Term Loan for The Children’s Place
-
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
-
Cat Tales Feline Health Center Celebrates First Anniversary With Major Milestones in Feline Care, Shelter Support, and Fear Free® Certification
-
Clifton Mining Company (OTCBB: CFTN) (Clifton) - "Distribution and Production Update"
-
Graton Resort & Casino Hosts World Premiere of New BOMBERMAN Slot Games
-
Mutuum Finance (MUTM) Strengthens Security Framework with CertiK Review and Active Halborn Audit
-
Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
-
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
-
Talisker Provides Update on Staff Reduction at Bralorne due to Atmospheric River Event in Southern British Columbia
-
Nasdaq Maintains Over a Decade of Listings Leadership in 2025
-
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
-
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Lifecore Biomedical to be Added to Nasdaq Biotech Index
-
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
-
BitMart Launches Christmas Mega Giveaway with Over 1,000,000 USDT in Rewards
-
ONAR Holding Corporation Retires $311,000 in Debt Through Equity Conversion, Strengthens Balance Sheet, and Aligns Long-Term Partners with Shareholders
-
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
-
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
-
OTC Markets Group Welcomes Quartz Mountain Resources Ltd. to OTCQX
-
FactSet Reports Results for First Quarter Fiscal 2026
-
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
-
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
-
Viatris Provides Pipeline Update on Four Regulatory Milestones
